Institut Biochimique Drug Patent Portfolio
Institut Biochimique's Family Patents
Clinical Trials
Recent Clinical Trials by Institut Biochimique:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| A Controlled Study to Evaluate Efficacy and Safety of a Single Intra-Articular Injection of HL-01 in the Treatment of Pain in Symptomatic Knee Osteoarthritis | IBSA Institut Biochimique SA | NA |
NOT YET RECRUITING
(Sep 1, 2026)
| PHASE3 |
| Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. | IBSA Institut Biochimique SA | NA |
COMPLETED
(Aug 1, 2026)
| PHASE3 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List